Harnessing the Immune System to Provide Long-Term Survival in Patients With Melanoma and Other Solid Tumors

OncoImmunology - United States
doi 10.4161/onci.27560
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Harnessing the Immune System to Improve Cancer Therapy

Annals of Translational Medicine
Medicine
2016English

Percutaneous Irreversible Electroporation: Long-Term Survival Analysis of 71 Patients With Inoperable Malignant Hepatic Tumors

Scientific Reports
Multidisciplinary
2017English

Corrigendum: Association of CTLA-4 Gene Variants With Response to Therapy and Long-Term Survival in Metastatic Melanoma Patients Treated With Ipilimumab: An Italian Melanoma Intergroup Study

Frontiers in Immunology
AllergyImmunology
2018English

Melanoma Drug Works in Other Tumors

Cancer Discovery
Oncology
2015English

Twelve-Year Survival and Immune Correlates in Dendritic Cell–vaccinated Melanoma Patients

JCI insight
Medicine
2017English

Long-Term Postoperative Survival Prediction in Patients With Colorectal Liver Metastasis

Oncotarget
Oncology
2017English

Survival in Patients Treated by Long-Term Dialysis Compared With the General Population

American Journal of Kidney Diseases
Nephrology
2012English

Nomograms to Estimate Long-Term Overall Survival and Breast Cancer-Specific Survival of Patients With Luminal Breast Cancer

Oncotarget
Oncology
2016English

Practice Patterns and Long-Term Outcomes Among Patients With Pancreatic Giant Cell Tumors

HPB
HepatologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy